Tranexamic Acid Can Reduce Blood Loss in Adolescent Scoliosis Surgery: a Systematic Review and Meta-Analysis

Keyu Chen,Liang Wang,Qingyang Gao,Umar Masood,Zhimou Zeng,Huiliang Yang,Yueming Song
DOI: https://doi.org/10.1186/s12891-023-06811-1
IF: 2.562
2023-01-01
BMC Musculoskeletal Disorders
Abstract:Tranexamic acid (TXA) has been widely used in orthopedic surgery, but its efficacy in adolescent scoliosis (AS) surgery remains unclear in the literature. The purpose of this systematic review and meta-analysis is to evaluate the safety and efficacy of TXA compared to placebo treatment during or after AS surgery, by gathering data from randomized both controlled trials (RCTs) and non-RCTs. English and Chinese electronic databases including PubMed, Web of Science, Embase, Cochrane, CNKI, and Wan Fang database were searched to identify the relevant literature up until August 2022. The primary outcomes were intraoperative blood loss and total blood loss. The secondary outcomes included the need for transfusion, postoperative hemoglobin (Hb) level, and change in Hb level. Stata 17 was used for data analysis and the risk of bias was assessed. We followed the PRISMA checklist to ensure the quality of this article. Twelve studies (795 participants) were included in the meta-analysis for intraoperative blood loss during surgery. The results suggest that TXA can reduce the intraoperative blood loss of the patients (MD = -306.40ml, 95
What problem does this paper attempt to address?